Vortioxetine
Trintellix is a prescription brand name for vortioxetine, an oral tablet medication manufactured by Takeda Pharmaceuticals America, Inc. It is available in strengths of 5 mg, 10 mg, and 20 mg (15 mg discontinued). This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Trintellix is a prescription brand name for vortioxetine, an oral tablet medication manufactured by Takeda Pharmaceuticals America, Inc. It is available in strengths of 5 mg, 10 mg, and 20 mg (15 mg discontinued). This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Vortioxetine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Vortioxetine — ANDA 204447 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204447"
}
]
|
| identifier | ANDA204447 |
| issued | 2016-09-16 |
| keyword |
[
"drug-safety",
"fda",
"pharmaceuticals",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Vortioxetine |
